Analysis of microRNA-target interactions across diverse cancer types

Nature Structural and Molecular Biology

Volumn 20, Issue 11, 2013, Pages 1325-1332

  Jacobsen, Anders ^a   Silber, Joachim ^a   Harinath, Girish ^a   Huse, Jason T ^a   Schultz, Nikolaus ^a   Sander, Chris ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 29; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; COLON ADENOCARCINOMA; CYSTADENOCARCINOMA; DNA METHYLATION; ENDOMETRIOID CARCINOMA; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INVASIVE CARCINOMA; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; RECTUM CARCINOMA; REGULATORY MECHANISM; RNA ANALYSIS; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; UTERUS CARCINOMA;

COMPUTATIONAL BIOLOGY; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOPLASMS; RNA, MESSENGER;

EID: 84887499256     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2678     Document Type: Article

References (49)

1. Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
2. Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714 (2009).
3. Lujambio, A. & Lowe, S.W. The microcosmos of cancer. Nature 482, 347-355 (2012).
4. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
5. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261 (2006).
6. Medina, P.P., Nolde, M. & Slack, F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90 (2010).
7. Garzon, R., Marcucci, G. & Croce, C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 9, 775-789 (2010).
8. Jacobsen, A., Wen, J., Marks, D.S. & Krogh, A. Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res. 20, 1010-1019 (2010).
9. Domcke, S., Sinha, R., Levine, D.A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).
10. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
11. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
12. Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64-71 (2008).
13. Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63 (2008).
14. Huang, J.C. et al. Using expression profiling data to identify human microRNA targets. Nat. Methods 4, 1045-1049 (2007).
15. Muniategui, A., Pey, J., Planes, F.J. & Rubio, A. Joint analysis of miRNA and mRNA expression data. Brief. Bioinform. 14, 263-278 (2013).
16. Silber, J. et al. miR-34a Repression in proneural malignant gliomas upregulates expression of its Target PDGFRA and promotes tumorigenesis. PLoS ONE 7, e33844 (2012).
17. Genovese, G. et al. microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-? signaling in glioblastoma. Cancer Discov. 2, 736-749 (2012).
18. Setty, M. et al. Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma. Mol. Syst. Biol. 8, 605 (2012).
19. Creighton, C.J. et al. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS ONE 7, e34546 (2012).
20. Yang, D. et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23, 186-199 (2013).
21. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105 (2007).
22. Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional nonconserved and noncanonical sites. Genome Biol. 11, R90 (2010).
23. Kim, K. et al. Identification of oncogenic microRNA-17-92/ZBTB4/ specificity protein axis in breast cancer. Oncogene 31, 1034-1044 (2012).
24. Kim, K. et al. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters. Mol. Cancer Ther. 11, 1852-1862 (2012).
25. Brabletz, S. & Brabletz, T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670-677 (2010).
26. Dews, M. et al. The Myc-miR-17 92 axis blunts TGF signaling and production of multiple TGF-dependent antiangiogenic factors. Cancer Res. 70, 8233-8246 (2010).
27. Mestdagh, P. et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-? pathway in neuroblastoma. Mol. Cell 40, 762-773 (2010).
28. Akhurst, R.J. & Hata, A. Targeting the TGF? signalling pathway in disease. Nat. Rev. Drug Discov. 11, 790-811 (2012).
29. Hocevar, B.A., Smine, A., Xu, X.X. & Howe, P.H. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. EMBO J. 20, 2789-2801 (2001).
30. Hannigan, A. et al. Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J. Clin. Invest. 120, 2842-2857 (2010).
31. Mermel, C.H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
32. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
33. Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303 (2011).
34. He, Y.-F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307 (2011).
35. Cortellino, S. et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146, 67-79 (2011).
36. Garzon, R. et al. MicroRNA 29b functions in acute myeloid leukemia. Blood 114, 5331-5341 (2009).
37. Sengupta, S. et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. USA 105, 5874-5878 (2008).
38. Nam, Y., Chen, C., Gregory, R.I., Chou, J.J. & Sliz, P. Molecular Basis for Interaction of let-7 MicroRNAs with Lin28. Cell 147, 1080-1091 (2011).
39. Mariani, L. et al. Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res. 61, 4190-4196 (2001).
40. Penn, J.W., Grobbelaar, A.O. & Rolfe, K.J. The role of the TGF-? family in wound healing, burns and scarring: a review. Int. J. Burns Trauma 2, 18 (2012).
41. Bhutani, N., Burns, D.M. & Blau, H.M. DNA demethylation dynamics. Cell 146, 866-872 (2011).
42. Dawson, M.A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27 (2012).
43. Zhang, P., Huang, B., Xu, X. & Sessa, W.C. Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a. Biochem. Biophys. Res. Commun. 437, 368-373 (2013).
44. Fabbri, M. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 104, 15805-15810 (2007).
45. Garzon, R. et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113, 6411-6418 (2009).
46. López-Romero, P. Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library. BMC Genomics 12, 64 (2011).
47. Jacobsen, A., Krogh, A., Kauppinen, S. & Lindow, M. miRMaid: a unified programming interface for microRNA data resources. BMC Bioinformatics 11, 29 (2010).
48. Bhattacharyya, M., Das, M. & Bandyopadhyay, S. miRT: a database of validated transcription start sites of human microRNAs. Genomics Proteomics Bioinformatics 10, 310-316 (2012).
49. Frankel, L.B. et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033 (2008).